3'-Deoxy-3'-fluorothymidine(CAS: 25526-93-6)

3'-Deoxy-3'-fluorothymidine (CAS: 25526-93-6) falls under the scope of regulatory guidelines such as GHS classification for hazardous materials. It is also subject to REACH regulations in the European Union, requiring manufacturers to register the substance if the annual tonnage exceeds the threshold. Additionally, FDA and EPA regulations may apply in the United States, particularly for its use in pharmaceuticals and environmental releases.

Several alternatives to 3'-Deoxy-3'-fluorothymidine (CAS: 25526-93-6) exist in synthesis, including fluorodeoxyuridine and other 3'-deoxy analogs. Common alternative reagents such as 3'-deoxy-3'-bromothymidine can also be used depending on the specific synthesis requirements and desired outcomes.

The market for 3'-Deoxy-3'-fluorothymidine (CAS: 25526-93-6) is growing due to its potential applications in antiviral and antitumor drug development. Research trends indicate increasing focus on its use in targeted therapies and as an intermediate in the synthesis of complex organic compounds. Market trends show rising demand, particularly in pharmaceutical and chemical research sectors.

Waste containing 3'-Deoxy-3'-fluorothymidine (CAS: 25526-93-6) should be collected in appropriate containers and disposed of by incineration or professional waste disposal services. Environmental protection measures include proper sealing of waste to prevent leakage and ensuring that the disposal process complies with local and international regulations to minimize environmental impact.